- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Romeoville Today
By the People, for the People
Solésence Reports Record $62.1M in 2025 Revenue
Beauty and life sciences company sees strong growth, launches strategic initiative to drive future expansion.
Mar. 31, 2026 at 1:24pm
Got story updates? Submit your updates here. ›
Solésence's strategic investments in innovation and operational excellence have fueled the company's record financial performance and positioned it for continued growth in the competitive beauty and personal care market.Romeoville TodaySolésence, Inc., a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the fourth quarter and full year 2025, reporting record revenue of $62.1 million for the year, a 19% increase over 2024.
Why it matters
Solésence's strong financial performance and strategic initiatives demonstrate its ability to capitalize on the growing demand for innovative, science-backed beauty and personal care products, positioning the company for continued growth in a competitive market.
The details
In 2025, Solésence effectively doubled its line of consumer products in just two years, affirming the value it brings to the industry and its position as a leading innovator and manufacturer of SPF-infused beauty products. The company also launched a broad-based strategic initiative called 'Transform & Transcend' to align its operational execution with changes in the organization brought on by rapid commercial growth, enabling it to further capitalize on its market position and intellectual property investments.
- Solésence reported record revenue of $62.1 million for the full year 2025, a 19% increase over 2024.
- The company will host its fourth quarter 2025 conference call on Tuesday, March 31, 2026 at 7:30 a.m. CT.
The players
Kevin Cureton
President and Chief Executive Officer of Solésence.
Laura Riffner
Chief Financial Officer of Solésence.
Solésence, Inc.
A leader in scientifically-driven health care solutions across beauty and life science categories.
Yoolie Park
Vice President of Brand Partnerships at Solésence, responsible for driving the company's commercialization strategy and expanding relationships with beauty brand partners.
What they’re saying
“In 2025, we achieved record revenue of $62.1 million, effectively doubling our line of consumer products in just two years. This affirmed both the value we bring to the industry, and our ability to establish ourselves as a leading innovator and manufacturer of SPF-infused beauty products.”
— Kevin Cureton, President and Chief Executive Officer
“We exited 2025 with strong momentum due in part to organizational changes and the start of the Transform and Transcend initiative. Looking ahead to 2026, we are confident in our ability to deliver against our full-year objectives.”
— Laura Riffner, Chief Financial Officer
What’s next
Solésence will host its fourth quarter 2025 conference call on Tuesday, March 31, 2026 at 7:30 a.m. CT to discuss its financial results and provide a business and financial update.
The takeaway
Solésence's strong financial performance and strategic initiatives demonstrate its ability to capitalize on the growing demand for innovative, science-backed beauty and personal care products, positioning the company for continued growth in a competitive market.
